262 related articles for article (PubMed ID: 37098558)
1. The association between risk perceptions, anxiety, and self-reported changes in tobacco and nicotine product use due to COVID-19 in May-June 2020 in Israel.
Rubinson NG; Fong GT; Gravely S; Quah ACK; Bitan M; Lev Ari S; Rosen LJ
BMC Public Health; 2023 Apr; 23(1):759. PubMed ID: 37098558
[TBL] [Abstract][Full Text] [Related]
2. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
[TBL] [Abstract][Full Text] [Related]
3. Harm perceptions of nicotine-containing products and associated sources of information in UK adults with and without mental ill health: A cross-sectional survey.
Perman-Howe PR; Horton M; Robson D; McDermott MS; McNeill A; Brose LS
Addiction; 2022 Mar; 117(3):715-729. PubMed ID: 34338387
[TBL] [Abstract][Full Text] [Related]
4. Free-Base and Total Nicotine, Reactive Oxygen Species, and Carbonyl Emissions From IQOS, a Heated Tobacco Product.
Salman R; Talih S; El-Hage R; Haddad C; Karaoghlanian N; El-Hellani A; Saliba NA; Shihadeh A
Nicotine Tob Res; 2019 Aug; 21(9):1285-1288. PubMed ID: 30476301
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product (
Afolalu EF; Langer P; Fischer K; Roulet S; Magnani P
F1000Res; 2021; 10():504. PubMed ID: 35528952
[No Abstract] [Full Text] [Related]
6. 'It's not what you'd term normal smoking': a qualitative exploration of language used to describe heated tobacco product use and associated user identity.
East KA; Miller CR; Hitchman SC; McNeill A; Tompkins CNE
Addiction; 2023 Mar; 118(3):533-538. PubMed ID: 36148622
[TBL] [Abstract][Full Text] [Related]
7. Nicotine Delivery and User Ratings of IQOS Heated Tobacco System Compared With Cigarettes, Juul, and Refillable E-Cigarettes.
Phillips-Waller A; Przulj D; Pesola F; Smith KM; Hajek P
Nicotine Tob Res; 2021 Oct; 23(11):1889-1894. PubMed ID: 33983450
[TBL] [Abstract][Full Text] [Related]
8. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence.
Leventhal AM; Strong DR; Kirkpatrick MG; Unger JB; Sussman S; Riggs NR; Stone MD; Khoddam R; Samet JM; Audrain-McGovern J
JAMA; 2015 Aug; 314(7):700-7. PubMed ID: 26284721
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
Li L; Borland R; Cummings KM; Gravely S; Quah ACK; Fong GT; Miller CR; Goniewicz ML; Le Grande M; McNeill A
Nicotine Tob Res; 2021 Aug; 23(9):1611-1616. PubMed ID: 33693833
[TBL] [Abstract][Full Text] [Related]
10. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Heated Tobacco Product Use Among Adult Cigarette Smokers and Nicotine Vaping Product Users in the 2018 ITC Four Country Smoking & Vaping Survey.
Miller CR; Sutanto E; Smith DM; Hitchman SC; Gravely S; Yong HH; Borland R; O'Connor RJ; Cummings KM; Fong GT; Hyland A; Quah ACK; Goniewicz ML
Nicotine Tob Res; 2022 Mar; 24(4):493-502. PubMed ID: 34669964
[TBL] [Abstract][Full Text] [Related]
12. Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.
Gaiha SM; Lempert LK; Halpern-Felsher B
JAMA Netw Open; 2020 Dec; 3(12):e2027572. PubMed ID: 33270127
[TBL] [Abstract][Full Text] [Related]
13. Smoking and E-Cigarette Use Among U.S. Adults During the COVID-19 Pandemic.
Kalkhoran SM; Levy DE; Rigotti NA
Am J Prev Med; 2022 Mar; 62(3):341-349. PubMed ID: 34756629
[TBL] [Abstract][Full Text] [Related]
14. How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes.
Czoli CD; Fong GT; Mays D; Hammond D
Tob Control; 2017 Mar; 26(e1):e49-e58. PubMed ID: 27625408
[TBL] [Abstract][Full Text] [Related]
15. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic.
Streck JM; Kalkhoran S; Bearnot B; Gupta PS; Kalagher KM; Regan S; Wakeman S; Rigotti NA
Drug Alcohol Depend; 2021 Jan; 218():108438. PubMed ID: 33271434
[TBL] [Abstract][Full Text] [Related]
16. Individual and Conjoint Factors Associated With Beliefs About the Harmfulness of Nicotine Replacement Therapies Relative to Combustible Cigarettes Among People Who Smoke: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
Yong HH; Karmakar C; Motin MA; Borland R; Cummings KM; Gravely S; Fong GT
Nicotine Tob Res; 2023 Aug; 25(9):1594-1602. PubMed ID: 37195899
[TBL] [Abstract][Full Text] [Related]
17. The role of IQOS risk perceptions on cigarette smoking behaviours: results from a prospective pilot study.
DeAtley T; Stone MD; Strasser AA; Audrain-McGovern J
Tob Control; 2024 Feb; 33(2):263-266. PubMed ID: 36002165
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette.
Goldenson NI; Augustson EM; Chen J; Shiffman S
Psychopharmacology (Berl); 2022 Mar; 239(3):977-988. PubMed ID: 35184228
[TBL] [Abstract][Full Text] [Related]
19. Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 "lockdown": A qualitative study in the United States.
Giovenco DP; Spillane TE; Maggi RM; Lee EY; Philbin MM
Int J Drug Policy; 2021 Aug; 94():103175. PubMed ID: 33662811
[TBL] [Abstract][Full Text] [Related]
20. Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey.
Sharma A; Fix B; Hyland A; Bansal-Travers M; Quisenberry A; O'Connor R
Front Public Health; 2023; 11():1307484. PubMed ID: 38269390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
